Evaluation of a synthetic peptide as a replacement for the recombinant fusion protein of respiratory syncytial virus in a potency ELISA
β Scribed by James B. McGivney IV; Eric Bishop; Kenneth Miller; Jose Casas-Finet; Harry Yang; Ziping Wei; Robert Strouse; Mark Schenerman
- Book ID
- 108189834
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 172 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0731-7085
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Diagnostic reagents for detection of human immunodeficiency virus (HIV) exposure with improved reliability may be provided by viral encoded proteins produced by recombinant DNA techniques or by synthetic peptides corresponding to appropriate viral epitopes. We have expressed at high levels in E. col
## Abstract Two synthetic peptides, designated peptides 12G(A) and 12G(B), representing amino acids 174β188 of the G glycoprotein of respiratory syncytial virus (RSV) subgroup A (strain A2) and subgroup B (strain CH18537) were evaluated for their properties as subgroupβspecific antigens for enzyme
Comparisons were made between standard methods of cell culture, indirect immunofluorescence (IF) using hyperimmune respiratory syncytial virus (RSV) antiserum, and indirect IF using mouse monoclonal antibodies directed against various epitopes of RSV for the detection of RSV in nasopharyngeal aspira